Admin
23 August 2023

Shelter Pharma Limited IPO: Crafting Wellness Through Nature

Introduction:

Established in 2007, Shelter Pharma Limited (formerly known as Shelter Pharmacy) is a prominent player in the field of manufacturing herbal products, catering to both human and veterinary healthcare. The company is headquartered in Himmatnagar, Gujarat, and is dedicated to providing cost-effective and superior solutions to health issues in humans and animals.

Diverse Portfolio:

Shelter Pharma specializes in the production of herbal medicines spanning across human healthcare, veterinary care, and poultry care. Their comprehensive range of health supplements is designed to enhance the well-being of humans and poultry alike. The company embraces a harmonious blend of Ayurvedic principles with modern innovations.

Product Range:

For Human Healthcare, Shelter Pharma offers products such as Lemonade Barley Water, Sherolax, Baldeepak, and Stonyl Tablets. In the Veterinary Healthcare segment, their offerings include Agrical Powder, Lactocal Gel, and Shelodex Ultra Ointment. These products cater to a clientele mainly from rural and semi-urban markets.

Holistic Approach:

Shelter Pharma's philosophy revolves around integrating the principles of Ayurveda with contemporary advancements. This approach ensures that their products are not only effective but also natural and safe.

IPO Details:

Shelter Pharma is now set to embark on a new phase of growth through its Initial Public Offering (IPO). The IPO comes with a total issue size of Rs. 16.03 Crores and a fixed price of Rs. 42 per share. The company's shares are slated to be listed on BSE SME.

Financial Snapshot

Here's a glimpse of the company's financial performance:

Financial Year Ended	Assets (₹ Lakhs)	Revenue (₹ Lakhs)	Profit After Tax (₹ Lakhs)	Net Worth (₹ Lakhs)
31-Mar-21	1020.24	2248.86	-23.88	711.17
31-Mar-22	1283.93	3005.84	183.70	880.42
31-Mar-23	2144.90	3615.51	578.33	1451.06

Expert Opinion:

While Shelter Pharma operates in a promising sector, its exceptional profits for FY23 are raising questions about their sustainability. The IPO appears attractive with a low P/E ratio of 5.62 based on these remarkable earnings. However, investors are advised to be cautious and thoroughly assess the long-term sustainability before making investment decisions.

In a Nutshell:

Shelter Pharma's IPO offers investors an opportunity to embrace the potential of herbal healthcare solutions. With a strong focus on natural wellness and a diverse product range, Shelter Pharma is carving its niche in the healthcare industry. Potential investors are encouraged to delve into the comprehensive information provided here and make informed investment choices.

Read More IPO related blogs - Srivari Spices and Foods Limited IPO